Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Coremap Inc. is currently managing 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. This level of activity indicates a targeted pursuit of patent rights for its mechanical or medical technologies. The focus on this specific technology area suggests that the company's current intellectual property efforts are concentrated on hardware or device-based innovations.
The prosecution of these matters is split between 2 distinct examiners and 2 distinct art units. This distribution means that each of the 2 pending office actions is being evaluated independently by different officials in different specialized sections of the USPTO. By engaging with 2 distinct art units, the company is subject to different technical review standards, which can provide a more varied perspective on the patentability of its inventions.
JOHNSON, NICOLE F is the busiest examiner for the portfolio, currently handling 1 pending office action. Because the workload is shared equally between two officials, the company's success depends on navigating the specific preferences of both examiners. Practitioners should be prepared to tailor their arguments to the 2 distinct art units involved to move the 2 pending office actions toward allowance in the Medical Devices & Mechanical Engineering field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHNSON, NICOLE F | 1 | 87.4% | +7.0% |
| EVANISKO, GEORGE ROBERT | 1 | 70.4% | +34.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18627895 | ALGORITHMIC TECHNIQUES FOR DEDUCTION OF FUNCTIONAL CHARACTERISTICS OF CARDIAC TISSUE IN CARDIAC ELECTRICAL FIBRILLATION FROM A DENSELY PACKED ARRAY OF HIGH-RESOLUTION ELECTRODES | JOHNSON, NICOLE F | 29d |
| 17507102 | COMMON MODE REJECTION CONFIGURATION FOR IMPROVING SPATIAL RESOLUTION | EVANISKO, GEORGE ROBERT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17507102 | COMMON MODE REJECTION CONFIGURATION FOR IMPROVING SPATIAL RESOLUTION | EVANISKO, GEORGE ROBERT | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18627895 | ALGORITHMIC TECHNIQUES FOR DEDUCTION OF FUNCTIONAL CHARACTERISTICS OF CARDIAC TISSUE IN CARDIAC ELECTRICAL FIBRILLATION FROM A DENSELY PACKED ARRAY OF HIGH-RESOLUTION ELECTRODES | JOHNSON, NICOLE F | 3796 | §103§112Other | Final Rejection | 29d | Pending | Apr 05, 2024 |
| 17507102 | COMMON MODE REJECTION CONFIGURATION FOR IMPROVING SPATIAL RESOLUTION | EVANISKO, GEORGE ROBERT | 3792 | §102§103§112 | Final Rejection | — | Pending | Oct 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial